Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...